|
Clinical and 2-D echocardiographic findings in all patients (n = 100) |
|||
| Characteristics |
CHF (n = 50) |
CS (n = 50) |
p-value |
|
|
|||
| Age (y) |
57 ± 13 |
58 ± 10 |
0.88 |
| Male Gender (%) |
30 (60) |
29 (58) |
1.00 |
| Diabetes mellitus (%) |
30 (60) |
32 (64) |
0.90 |
| Hypertension (%) |
35 (70) |
37 (74) |
0.78 |
| Dyslipidemia (%) |
25 (50) |
23 (46) |
0.90 |
| Smoking history (%) |
34 (68) |
32 (64) |
0.82 |
|
|
|||
| Cardiac medications |
|||
|
|
|||
| Beta blockers (%) |
50 (100) |
10 (20) |
< 0.05 |
| ACE inhibitors (%) |
48 (96) |
5 (10) |
< 0.05 |
| Digoxin (%) |
25 (50) |
5 (10) |
< 0.05 |
| Spironolactone (%) |
32 (64) |
0 (0) |
< 0.05 |
| Inotropic support (%) |
0 (0) |
50 (100) |
< 0.05 |
|
|
|||
| Left Heart Dimensions |
|||
|
|
|||
| IVS (mm) |
10 ± 2 |
11 ± 2 |
0.87 |
| PWT (mm) |
11 ± 2 |
11 ± 1 |
0.90 |
| LVEDD (mm) |
60 ± 2 |
59 ± 3 |
0.85 |
| EF (%) |
25 ± 6 |
23 ± 7 |
0.82 |
|
Values are mean ± SD (percentage). CHF, congestive heart failure; CS, cardiogenic shock; y, years; IVS, interventricular septal thickness; PWT, posterior wall thickness; LVEDD, left ventricular end diastolic diameter; EF, ejection fraction. p < 0.05* was considered significant. | |||
Hameed et al. Cardiovascular Ultrasound 2008 6:11 doi:10.1186/1476-7120-6-11 |
|||